What are the Complications of Three-dimensionally Printed, Custom-made, Integrative Hemipelvic Endoprostheses in Patients with Primary Malignancies Involving the Acetabulum, and What is the Function of These Patients?


Journal

Clinical orthopaedics and related research
ISSN: 1528-1132
Titre abrégé: Clin Orthop Relat Res
Pays: United States
ID NLM: 0075674

Informations de publication

Date de publication:
11 2020
Historique:
pubmed: 19 5 2020
medline: 25 5 2021
entrez: 19 5 2020
Statut: ppublish

Résumé

Functional reconstruction after resection of pelvic malignancies involving the acetabulum remains challenging. Numerous reconstruction methods have been proposed, but they are generally associated with mechanical and nonmechanical complications. To improve the function of patients with primary malignancies of the acetabulum after internal hemipelvectomy and reduce the complication rate after this procedure, we designed a series of three-dimensionally (3D) printed, custom-made, integrative hemipelvic endoprostheses with a porous structure and wanted to present the early results of using this construct to determine whether it could be considered a reasonable reconstruction option. We performed this study to (1) evaluate, in a small group of patients, whether the new endoprosthesis restores short-term lower-limb function; (2) identify short-term complications associated with the use of this endoprosthesis; and (3) assess osseointegration between the host bone and the 3D-printed integrative hemipelvic endoprosthesis with a porous structure. Between October 2016 and May 2017, our center treated 26 patients with malignancies involving the acetabulum. Thirteen of these patients received hemipelvic replacement with a 3D-printed, custom-made, integrative endoprosthesis, six received hemipelvic replacement with a modular endoprosthesis, four received radiotherapy, and three received external hemipelvectomy. Resection and reconstruction with a 3D-printed, custom-made, integrative endoprosthesis were indicated if the resection margin was the same as that achieved in hemipelvectomy, if reconstruction would preserve reasonable function after resection, if the patient had a good physical status and life expectancy longer than 6 months, and if the patient was willing to accept the potential risk of a 3D-printed, custom-made, endoprosthesis. The exclusion criteria were an inability to achieve a satisfactory surgical margin with limb salvage, inability to preserve the function of the limb because of tumor involvement of the sacral nerve or sciatic nerve, and unresectable and/or widely metastatic disease on presentation. Pain and function were evaluated with the 10-cm VAS score (range 0 to 10; a lower score is desirable), the 1993 version of the Musculoskeletal Tumor Society (MSTS-93) score (range 0 to 30; a higher score is desirable), and the Harris hip score ([HHS]; range 0 to 100; a higher score is desirable) were evaluated preoperatively and at a median of 27 months after reconstruction (range 24 to 31 months). The functional scores and complications were recorded after reviewing the patients' records. Osseointegration was assessed with digital tomosynthesis by two senior surgeons. We observed the trabecular structures connected to the implant surface to assess whether there was good osseointegration. The median preoperative VAS score, MSTS-93 score, and HHS were 5 (range 2 to 8), 14 (range 3 to 18), and 64 (range 20 to 76) points, respectively. At the latest follow-up interval, the median VAS score, MSTS-93 score, and HHS were 2 (range 0 to 6), 23 (range 15 to 27), and 82 (range 44 to 93) points, respectively. No deep infection, dislocation, endoprosthetic breakage, aseptic loosening, or local recurrence occurred. Two patients experienced delayed wound healing; the wounds healed after débridement. Using digital tomography, we found that all implants were well-osseointegrated at the final follow-up examination. A 3D-printed, custom-made, integrative hemipelvic endoprosthesis provides acceptable early outcomes in patients undergoing pelvic reconstruction. Osseointegration is possible, and we anticipate this will lead to biologic stability with a longer follow-up interval. The custom-made integrative design ensured precise implantation. Although a few patients in this study had only a short follow-up duration, the functional results were reasonable. We have observed no major complications so far, but this was a very small series and we caution that these are large reconstructions that will certainly result in complications for some patients. Our method uses a precise preoperative simulation and endoprosthesis design to aid the surgeon in performing challenging operations. If our early results are confirmed with more patients and longer follow-up and are replicated at other centers, this may be a reconstruction option for patients with periacetabular malignancies. Level IV, therapeutic study.

Sections du résumé

BACKGROUND
Functional reconstruction after resection of pelvic malignancies involving the acetabulum remains challenging. Numerous reconstruction methods have been proposed, but they are generally associated with mechanical and nonmechanical complications. To improve the function of patients with primary malignancies of the acetabulum after internal hemipelvectomy and reduce the complication rate after this procedure, we designed a series of three-dimensionally (3D) printed, custom-made, integrative hemipelvic endoprostheses with a porous structure and wanted to present the early results of using this construct to determine whether it could be considered a reasonable reconstruction option.
QUESTIONS/PURPOSES
We performed this study to (1) evaluate, in a small group of patients, whether the new endoprosthesis restores short-term lower-limb function; (2) identify short-term complications associated with the use of this endoprosthesis; and (3) assess osseointegration between the host bone and the 3D-printed integrative hemipelvic endoprosthesis with a porous structure.
METHODS
Between October 2016 and May 2017, our center treated 26 patients with malignancies involving the acetabulum. Thirteen of these patients received hemipelvic replacement with a 3D-printed, custom-made, integrative endoprosthesis, six received hemipelvic replacement with a modular endoprosthesis, four received radiotherapy, and three received external hemipelvectomy. Resection and reconstruction with a 3D-printed, custom-made, integrative endoprosthesis were indicated if the resection margin was the same as that achieved in hemipelvectomy, if reconstruction would preserve reasonable function after resection, if the patient had a good physical status and life expectancy longer than 6 months, and if the patient was willing to accept the potential risk of a 3D-printed, custom-made, endoprosthesis. The exclusion criteria were an inability to achieve a satisfactory surgical margin with limb salvage, inability to preserve the function of the limb because of tumor involvement of the sacral nerve or sciatic nerve, and unresectable and/or widely metastatic disease on presentation. Pain and function were evaluated with the 10-cm VAS score (range 0 to 10; a lower score is desirable), the 1993 version of the Musculoskeletal Tumor Society (MSTS-93) score (range 0 to 30; a higher score is desirable), and the Harris hip score ([HHS]; range 0 to 100; a higher score is desirable) were evaluated preoperatively and at a median of 27 months after reconstruction (range 24 to 31 months). The functional scores and complications were recorded after reviewing the patients' records. Osseointegration was assessed with digital tomosynthesis by two senior surgeons. We observed the trabecular structures connected to the implant surface to assess whether there was good osseointegration.
RESULTS
The median preoperative VAS score, MSTS-93 score, and HHS were 5 (range 2 to 8), 14 (range 3 to 18), and 64 (range 20 to 76) points, respectively. At the latest follow-up interval, the median VAS score, MSTS-93 score, and HHS were 2 (range 0 to 6), 23 (range 15 to 27), and 82 (range 44 to 93) points, respectively. No deep infection, dislocation, endoprosthetic breakage, aseptic loosening, or local recurrence occurred. Two patients experienced delayed wound healing; the wounds healed after débridement. Using digital tomography, we found that all implants were well-osseointegrated at the final follow-up examination.
CONCLUSIONS
A 3D-printed, custom-made, integrative hemipelvic endoprosthesis provides acceptable early outcomes in patients undergoing pelvic reconstruction. Osseointegration is possible, and we anticipate this will lead to biologic stability with a longer follow-up interval. The custom-made integrative design ensured precise implantation. Although a few patients in this study had only a short follow-up duration, the functional results were reasonable. We have observed no major complications so far, but this was a very small series and we caution that these are large reconstructions that will certainly result in complications for some patients. Our method uses a precise preoperative simulation and endoprosthesis design to aid the surgeon in performing challenging operations. If our early results are confirmed with more patients and longer follow-up and are replicated at other centers, this may be a reconstruction option for patients with periacetabular malignancies.
LEVEL OF EVIDENCE
Level IV, therapeutic study.

Identifiants

pubmed: 32420722
doi: 10.1097/CORR.0000000000001297
pmc: PMC7594920
pii: 00003086-202011000-00016
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2487-2501

Commentaires et corrections

Type : CommentIn

Références

Clin Orthop Relat Res. 1980 Nov-Dec;(153):106-20
pubmed: 7449206
Int Orthop. 2012 Dec;36(12):2529-36
pubmed: 23090357
Eur J Surg Oncol. 2013 Jan;39(1):53-60
pubmed: 23131428
Clin Orthop Relat Res. 2004 Feb;(419):165-72
pubmed: 15021149
Bone Joint J. 2019 Apr;101-B(4):484-490
pubmed: 30929483
Arch Orthop Trauma Surg. 1997;116(1-2):27-31
pubmed: 9006761
Bone Joint J. 2014 Mar;96-B(3):399-405
pubmed: 24589799
Hip Int. 2016 Mar 23;26(2):e14-8
pubmed: 26868113
Clin Orthop Relat Res. 1993 Jan;(286):241-6
pubmed: 8425352
Comput Aided Surg. 2015;20(1):14-23
pubmed: 26290317
Clin Orthop Relat Res. 2017 Mar;475(3):735-741
pubmed: 26883656
J Bone Joint Surg Am. 1978 Sep;60(6):731-46
pubmed: 701308
ScientificWorldJournal. 2014 Jan 27;2014:605019
pubmed: 24616637
Clin Orthop Relat Res. 2018 Sep;476(9):1762-1770
pubmed: 30794213
Clin Orthop Relat Res. 2011 May;469(5):1450-8
pubmed: 21312077
Med Eng Phys. 2015 Jan;37(1):109-20
pubmed: 25498138
J Surg Oncol. 2018 Jun;117(7):1455-1463
pubmed: 29473959
J Arthroplasty. 2007 Oct;22(7):981-6
pubmed: 17920469
Int Orthop. 2018 Aug;42(8):1987-1997
pubmed: 29460155
Clin Orthop Relat Res. 2002 Mar;(396):197-205
pubmed: 11859244
J Arthroplasty. 2019 Feb;34(2):338-345.e1
pubmed: 30497901
Oncol Lett. 2015 Dec;10(6):3529-3531
pubmed: 26788163
Clin Orthop Relat Res. 1991 Sep;(270):149-58
pubmed: 1884534
Bone Joint J. 2014 Oct;96-B(10):1404-10
pubmed: 25274929
Bone Joint J. 2017 Feb;99-B(2):267-275
pubmed: 28148672
J Bone Joint Surg Am. 2017 Feb 1;99(3):e9
pubmed: 28145959
Comput Aided Surg. 2007 Jul;12(4):225-32
pubmed: 17786598
J Bone Joint Surg Am. 2009 Jan;91(1):142-51
pubmed: 19122089
Clin Orthop Relat Res. 2013 Jan;471(1):324-31
pubmed: 23054524
Scand J Pain. 2016 Oct;13:67-75
pubmed: 28850536
PLoS One. 2015 May 26;10(5):e0127263
pubmed: 26011448
Clin Orthop Relat Res. 2009 Nov;467(11):2825-30
pubmed: 19384561
Int Orthop. 2019 Jan;43(1):123-132
pubmed: 30467646
Orthop Traumatol Surg Res. 2019 Jun;105(4):781-787
pubmed: 30982774
Clin Orthop Relat Res. 1996 Oct;(331):265-76
pubmed: 8895649
J Surg Oncol. 2012 Sep 15;106(4):417-22
pubmed: 22457213
Int Orthop. 2002;26(2):76-9
pubmed: 12078881
J Arthroplasty. 2018 May;33(5):1579-1587
pubmed: 29366729
J Surg Oncol. 2011 Mar 1;103(3):269-75
pubmed: 21337556
Clin Orthop Relat Res. 2019 Aug;477(8):1892-1901
pubmed: 30985613
Int Orthop. 2014 Jul;38(7):1435-42
pubmed: 24658873
Eur J Surg Oncol. 2009 Dec;35(12):1318-25
pubmed: 19477098
J Arthroplasty. 2011 Dec;26(8):1508-13
pubmed: 21477973
J Bone Joint Surg Br. 1997 Sep;79(5):773-9
pubmed: 9331034
Int Orthop. 2018 Mar;42(3):687-694
pubmed: 28956108
Bone Joint J. 2017 Jun;99-B(6):841-848
pubmed: 28566407
Cancer. 1979 Mar;43(3):806-9
pubmed: 284841
Clin Orthop Relat Res. 2007 Aug;461:180-8
pubmed: 17452921
Clin Orthop Relat Res. 2017 Mar;475(3):686-695
pubmed: 27020434
Osaka City Med J. 1997 Dec;43(2):173-83
pubmed: 9540340
J Bone Joint Surg Am. 1978 Sep;60(6):719-30
pubmed: 701307
J Bone Joint Surg Am. 1969 Jun;51(4):737-55
pubmed: 5783851
J Arthroplasty. 2014 Dec;29(12):2280-4
pubmed: 24961891
J Bone Joint Surg Br. 2008 Sep;90(9):1222-7
pubmed: 18757964

Auteurs

Jie Wang (J)

J. Wang, L. Min, M. Lu, Y. Zhang, Y. Wang, Y. Luo, Y. Zhou, H. Duan, C. Tu, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
J. Wang, L. Min, M. Lu, Y, Zhang, Y. Luo, Y. Zhou, C. Tu, Bone and Joint 3D-Printing and Biomechanical Laboratory, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Li Min (L)

J. Wang, L. Min, M. Lu, Y. Zhang, Y. Wang, Y. Luo, Y. Zhou, H. Duan, C. Tu, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
J. Wang, L. Min, M. Lu, Y, Zhang, Y. Luo, Y. Zhou, C. Tu, Bone and Joint 3D-Printing and Biomechanical Laboratory, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Minxun Lu (M)

J. Wang, L. Min, M. Lu, Y. Zhang, Y. Wang, Y. Luo, Y. Zhou, H. Duan, C. Tu, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
J. Wang, L. Min, M. Lu, Y, Zhang, Y. Luo, Y. Zhou, C. Tu, Bone and Joint 3D-Printing and Biomechanical Laboratory, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Yuqi Zhang (Y)

J. Wang, L. Min, M. Lu, Y. Zhang, Y. Wang, Y. Luo, Y. Zhou, H. Duan, C. Tu, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
J. Wang, L. Min, M. Lu, Y, Zhang, Y. Luo, Y. Zhou, C. Tu, Bone and Joint 3D-Printing and Biomechanical Laboratory, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Yitian Wang (Y)

J. Wang, L. Min, M. Lu, Y. Zhang, Y. Wang, Y. Luo, Y. Zhou, H. Duan, C. Tu, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Yi Luo (Y)

J. Wang, L. Min, M. Lu, Y. Zhang, Y. Wang, Y. Luo, Y. Zhou, H. Duan, C. Tu, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
J. Wang, L. Min, M. Lu, Y, Zhang, Y. Luo, Y. Zhou, C. Tu, Bone and Joint 3D-Printing and Biomechanical Laboratory, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Yong Zhou (Y)

J. Wang, L. Min, M. Lu, Y. Zhang, Y. Wang, Y. Luo, Y. Zhou, H. Duan, C. Tu, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
J. Wang, L. Min, M. Lu, Y, Zhang, Y. Luo, Y. Zhou, C. Tu, Bone and Joint 3D-Printing and Biomechanical Laboratory, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Hong Duan (H)

J. Wang, L. Min, M. Lu, Y. Zhang, Y. Wang, Y. Luo, Y. Zhou, H. Duan, C. Tu, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Chongqi Tu (C)

J. Wang, L. Min, M. Lu, Y. Zhang, Y. Wang, Y. Luo, Y. Zhou, H. Duan, C. Tu, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
J. Wang, L. Min, M. Lu, Y, Zhang, Y. Luo, Y. Zhou, C. Tu, Bone and Joint 3D-Printing and Biomechanical Laboratory, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH